Skip to main content

Morningside — Portfolio, Page 4

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

113
Companies
$2.0B
Total invested
$23.6M
Avg. check
39
Industries
Health Care 15Biotechnology 9Medical 8Software 5Therapeutics 5Information Technology 4+33 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 7396 of 113
Stavvy
December 2022

Stavvy is a modern lending experience connecting lenders with their title, settlement, and appraisal vendors.

FinTech · Boston$10.0M Debt Financing
Resilience Lab
November 2022

Resilience Lab is modernizing how clinicians work together to provide mental health care that’s high-quality, personalized, and accessible.

Health Care · New York$15.0M Series A
Cognoa
November 2022

Cognoa is a behavioral health company.

Biotechnology · Palo Alto$73.1M Series B
Otolith Labs
September 2022

Otolith Labs develops a therapeutic device for the treatment of vertigo.

Medical · Washington$20.0M Series A
Prospective Research
August 2022

Prospective Research is creating feed incorporated preventative disease management solutions.

Biotechnology · BeverlyConvertible Note
Adiso Therapeutics
March 2022

Adiso Therapeutics develops medications to treat inflammatory diseases.

Biotechnology · Concord$60.0M Series A
ThingsLog
January 2022

ThingsLog offers a complete solution for measurement, monitoring and alarming of water, gas and/or electricity consumption.

Information Technology · Sofia$1.1M Seed
Virtue Diagnostics
January 2022

Virtue Diagnostics is an innovative IVD company focused on infectious disease, cancer, and chronic diseases.

Health Care · Shanghai$100.0M Series B
Huckleberry Labs
November 2021

The source for family wellness, with the help of AI.

Artificial Intelligence (AI) · Irvine$12.5M Series A
Linus Health
July 2021

Linus Health is a digital health company focused on improving mental health and brain health by using screening technology.

Health Care · Waltham$55.0M Series B
Fount Bio
July 2021

Fount Bio is a life science company that applies proprietary advances in glycopolymer research for skin health.

Beauty · Cambridge$8.2M Series A
Eoitek
June 2021

Eoitek is an intelligent big data analysis solution provider.

Analytics · Shanghai$60.0M Series C
Nebula Microsystems Inc.
March 2021

Nebula Microsystems delivers intelligent and high-performance Analog Products for a wide variety of applications.

Manufacturing · Richardson$15.0M Seed
Arctic Vision
March 2021

Arctic Vision is focused on the development and commercialization of innovative ophthalmology therapies.

Biotechnology · Shanghai$100.0M Series B
Lele Ketang
September 2020

Lele Ketang is an online k to 12 education content and service platform.

Education · Beijing$40.0M Series C
Prescryptive Health
August 2020

Prescryptive Health is a digital health company focused on improving the prescription drug market.

Health Care · Washington$26.0M Series A
Heyuan Biotechnology
June 2020

Heyuan Biotechnology is a biotechnology company focusing on the field of gene therapy services.

Biotechnology · Shanghai$300.0M Series C
Inbilin
December 2019

Inbilin is a Voice call app company

Information Technology · PanyuSeries Unknown
Allysta
April 2019

Allysta is a biopharmaceutical company that develops therapeutic peptides for eye diseases.

Biotechnology · Bellevue$15.0M Series A
Apic Bio
January 2019

Apic Bio is a gene therapy company that develops treatment options for rare, undertreated neurological and liver diseases.

Biotechnology · Cambridge$42.3M Series A
Omni Prime
October 2018

Omni Prime provides Lending as a Service solution to retailers.

Financial Services · ShanghaiSeries D
Easyhin Technology
June 2018

Easyhin Technology is an mobile internet company on healthcare management of women and children.

Children · Shenzhen$22.9M Series C
Epivax Oncology
June 2018

Epivax Oncology is a providence, RI and NY-based precision cancer immunotherapy company.

Biotechnology · Providence$1.2M Series Unknown
Luqa Pharmaceuticals
May 2018

Luqa Pharmaceuticals is a China-focused company.

Health Care · Shangai$15.0M Series B

Where Morningside invests

Health Care15
Biotechnology9
Medical8
Software5
Therapeutics5
Information Technology4

About Morningside's portfolio

How many companies has Morningside invested in?

Morningside has invested in 113 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Morningside invest in?

Morningside's top investment sectors include Health Care, Biotechnology, Medical, Software, Therapeutics. The firm invests across 39 different industry categories.

What is Morningside's largest investment?

Among tracked funding rounds, Heyuan Biotechnology received $300.0M in a Series C round. Morningside's total known invested capital is $2.0B.

What is the average investment size for Morningside?

Morningside's average investment size is $23.6M across its portfolio of 113 companies.

What are Morningside's most recent investments?

Recent Morningside portfolio additions include Stavvy, Resilience Lab, Cognoa, Otolith Labs, Prospective Research. These companies were founded in 2020 or later.

Reach the founders behind these 113 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →